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Summary: Chronic liver damage is accompanied by both liver cell multiplication and stimulated synthesis of proteo-
glycans, but the relationship between the two biochemical processes has not been investigated so far. We found that
the incorporation of [14C]glucosamine into total glycosaminoglycans of rat liver slices from regenerating tissue is
depressed by about 50% 1 and 3 days after operation if referred to that measured in sham-operated control liver
slices. 6 h after partial hepatectomy [l4C]glucosamine incorporation into glycosaminoglycans is stimulated by more
than 30% in relation to sham operated livers. The proportional rates of synthesis of heparan sulfate and chondroitin
sulfate (about 8:1) did not change in regenerating liver tissue. Furthermore, there was no difference in the intracellular
uptake of [14C]glucosamine by rat liver slices from sham operated and partially hepatectomized rats; the pool size of
UDP-N-acetylhexosamine was only slightly larger (about 14%) under the latter experimental condition. We conclude
that liver regeneration by itself is not responsible for the elevated production and the changing pattern of proteo-
glycans in long-lasting hepatic injury.
Die in vitro Biosynthese der Glykosaminoglykane in der regenerierenden Rattenleber
Zusammenfassung: Chronische Leberschädigungen werden begleitet sowohl von Leberzellregeneration als auch stimu-
lierter Synthese von Proteoglykanen, aber die Beziehung zwischen beiden biochemischen Prozessen ist bis jetzt nicht
untersucht worden. Wir stellten fest, daß die Inkorporation von [14C]Glucosamin in die gesamten Glykosaminoglykane
der Rattenleberschnitte von regenerierendem Gewebe l und 3 Tage nach der Operation um etwa 50% gehemmt ist,
wenn die Einbaurate mit der in Explantaten von scheinoperierten Rattenlebern verglichen wird. 6 h nach partieller
Hepatektomie ist die [14C]Glucosamin-Einbaurate, verglichen mit schein-operierten Tieren, um mehr als 30% erhöht.
Die relativen Syntheseraten von Heparansulfat und Chöndroitiiisulfat (etwa 8: 1) verändern sich nicht im regene-
rierenden Lebergewebe. Überdies ließ sich kein Unterschied in der intrazellulären Aufnahme von [14C]Glucosamin
in Rattenleberschnitten von scheinoperierten und partiell hepatektomierten Ratten feststellen; die Poolgröße von
UDP-N-Acetylhexosaminen war nur geringfügig größer (etwa 14%) unter der letztgenannten experimentellen Bedin-
gung. Wir schließen aus den Ergebnissen, daß die Leberregeneration selbst nicht für die erhöhte Biosynthese und das
veränderte Muster der Proteoglykane in der langzeitig geschädigten Leber verantwortlich ist.
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proteoglycans (15-18) and collagens (19-21) in in-
jured liver but the stimulatory mechanisms are not
understood. In particular, it is not known whether there
is a causal link between increased synthesis of glycos-
aminoglycans in injured liver and hepatic regeneration,
i.e. whether the activation of glycosaminoglycan syn-
thesis is a biochemical feature of the pleiotypic
response of the actively dividing liver tissue (22). In
an attempt to answer this question we studied the syn-
thesis of sulfated glycosaminoglycans in liver explants
prepared from the regenerating tissue, in which the
factors of cell necrosis and consecutive inflammation,
associated with most models of experimental hepatic
fibrosis, are excluded.
Materials and Methods
Materials
£Ml-14C]glucosamine hydrochloride (291.6 GBq/ml - 7.88 Ci/
mol) and UDP-N-acetyl-D-[l-14C]gluc»samine (1.976 Bq/
mol = 53.4 Ci/mol) were obtained from New England Nuclear
Corp., Boston, USA; the commercial sources and specifications
of chondroitin AC lyases (EC 4.2.2.5), chondroitin ABC lyases
(EC 4.2.2.4), streptococcal hyaluronate lyases (EC 4.2.2.1),
papain (EC 3.4.22.2) and of unlabelled glycosaminoglycans
were as described previously (15).
Determination of the pool size of UDP-N-acetylhexosamines in
normal and regenerating liver
Immediately after decapitation the liver was transferred into
50 ml of icecold 0.75 mol/1 perchloric acid and homogenized
(15). The homogenate, from which an aliquot was taken for
the determination of the concentration of protein (23), was
centrifuged and the neutralized supernatant applied to a Dowex
1X8 column (0.7 X 12 cm). The nucleotide sugars eluted with
0.4 mol/1 of ammonium formate, pH 4.5 (24) were chromato-
graphed on Whatman 3 MM paper (2*5). The area cochromato-
graphing with authentic UDP-N-acetyl-/^(l-14C]glucpsamine
was excised from the. paper and eluted with water. The absorb^
ance at 260 n m of the eluate was measured and the concentration
determined by use of a standard curve containing known amounts
of UDP-N-acetylglucosamine. The total amount of UDP-N-acetyl-
hexosamiries was referred to liver protein (23).
Determination of the intracellular uptake of[14C]glucosamine
by cells in liver explants
After incubation the slices were washed extensively with ice-cold
phosphate-buffered saline containing 5 mmol/i unlabeled glucos-
amine and homogenized in 2 ml of cold water (15). The homo-
genate was treated with 60 g/1 trichloroacetic acid for l h at 0 °C;
after centrifugation the radioactivity of the supernatant was
measured (15).
Statistic analysis
The West for independent samples was applied (26).
Partial hepatectomy
Male Sprague-Dawley rats, weighing 180-250 g were fed ad
libitum with a standard rat diet and kept in a room with a con-
stant temperature (25 °C) and a 12 h light-darkness cycle.
Partial hepatectomy was carried out between 9 and 12 a.m.
under ether anesthesia by the method of Higgins & Anderson
(6). About 70% of the hepatic lobes was usually removed.
Sham-operated rats were treated similarly except that the
liver was replaced in the abdomen after being exposed for
about 20 s.
Preparation and incubation of liver slices
Rats were killed by decapitation between 9 and 11 a.m., except
those animals sacrificed 6 h after operation, and their livers
quickly removed, chilled and rinsed in ice-cold phosphate
buffered saline. Slices of 0-5 mm thickness (about 100 mg wet
weight) were prepared manually and incubated for 6 h at 37 °C
under 5% CO2-95% O2 in 3 ml ofDulbecco's modification of
Eagles medium (pH 7.4) containing 135 kBq (5 juCi) of D-
[l-14C)glucosamine hydrochloride and supplemented with
4 mmol/1 of /,-glutamine and 44 mmoi/1 of NaHCO3 (15).
Quantitäten of the incorporation of[l*C]hexosamine into
total and specific types of liver glycosaminoglycans
At the end of incubation liver slices were transferred into cold
acetone, delipidized and proteolyzed according to the procedure
described previously (15). Total glycosamiriogly cans'were preci-
pitated with cetylpyridinium chloride, their radioactivity
measured and referred to the protein content (23) of the liver
explant.
The radioactivity incorporated into specific types of glycos-
aminoglycans was quantitated by enzymatic degradation of total
glycosaminoglycans with chondroitin ABC lyases (chondroitin
sulfate and dermatan sulfate), chondroitin AC lyases (chondroitin
sulfate), and hyaluronate lyases (hyaluronic acid), by degradation
with nitrous acid (heparan sulfate and heparin), and by anion^
exchange Chromatographie procedures (keratan sulfate-like frac-
tion) as detailed elsewhere (15).
Results
In comparison with sham-operated and non-treated
livers the incorporation of [14C]glucosamine into total
glycosaminoglycans of slices from regenerating liver is
depressed by more than 40% 1 and 3 days after partial
hepatectomy. 6 h after partial liver resection the incorpor-
ation of the labeled amino sugar into glycosaminoglycans
is similar to that of unoperated rat livers but significant-
ly higher than that measured in sham-operated livers 6 h
after operation (tab. 1).
Nearly 90% of the label was found in the nitrous acid
labile fraction identified previously as heparan sulfate
(15), the remainder was degradable by chondroitin AC
lyase and, hence, represents chondroitin sulfate. In
accordance with published data (15) no incorpora-
tion of the amino sugar into dermatan sulfate was
detectable, and less than 1 % of the total glycosamino-
glycan associated radioactivity was localized in hyalur-
onic acid and a keratan sulfate-like fraction. The relative
rates of synthesis of hepatic heparan sulfate and chon-
droitin sulfate did not change 6 h, l d, and 3 d after
partial liver resection and were not different from those
measured in slices from sham-operated livers (tab. 2).
In order to exclude differences in the uptake of [14C]-
glucosamirie into cells of liver slices from regenerating
and sham-operated livers their acid-soluble, intracellular
radioactivity was determined at various times of incuba-
tion. It is shown in table 3 that during incubation the
amount of radioactivity is similar for both types of liver
slices thus ruling out impaired absorption of [14C]-
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Tab. 1 , The synthesis of total glycosaminoglycans in regenerating, sham-operated and non-operated rat liver. Slices prepared from the
hvers 6 h, 1 d, and 3 d after operation were incubated for 6 h in medium containing [14C]glucosamine. Total glycosamino-
glycans were isolated and their radioactivity (mean value ± S.D.) determined. The number of rats analysed is given in paren-
thesis. For 1 d after operation the incorporation into the glycosaminoglycans of the regenerating liver tissue is corrected for
the pool size of UDP-N-acetylhexosamine (tab. 4). The values are given in square brackets.
Time after
operation
6 h
I d
3d
Incorporation of l14C]hexosamine into glycosaminoglycans (Bq/mg protein)
Regenerating liver Sham-operated liver Non-operated liver
36.7
24.3
[27.9
24.5
±
±
±
±
5
9
10
3
.2 (6)
.0(11)
•3]
.0 (5)
P = 0.
P = 0.
P = 0.
030
015
030
27
42
45
.5±
.7±
.8±
6.0
5,9
23.0
(3)(5) P > 0.10
(3)
45.0 ±8.6 (6)
Tab 2. The proportional rates of synthesis of specific types of hepatic glycosaminoglycans in regenerating and sham-operated rat liver.
Liver slices prepared from rats sacrificed 6 h, 1 d, and 3 d after partial hepatectomy and sham-operation, respectively, were
incubated as described in table 1. The incorporation of [14C)hexosamine into the various types of glycosaminoglycans is
expressed as percentage of the incorporation into total glycosaminoglycans.
The number of rats analysed is given in parenthesis,'the values are the mean ± S.D.
Time after
operation
6h
I d
3d
Percentage of total glycosaminoglycan synthesis
Regenerating liver
Heparan sulfate Chondroitin sulfate
89.8 ± 2.6 (6)
87,3 ±4.5 (11)
91. 3 ±3.8 (5)
12.4 ± 1.1 (6)
12.0 ± 2.5 (11)
10.4 ± 1.9 (5)
Sham-operated liver
Heparan sulfate Chondroitin sulfate
89.1 ± 1.1 (3)
90.7 ± 2.1 (5)
90.2 ± 2.4 (3)
13.7 ± 0.5 (3)
12.8 ±2.8 (5)
9.8 ± 2.3 (3)
Tab. 3. Intracellular concentration of acid-soluble (14CJhexos-
amine in cells of slices from regenerating and sham-
operated liver 1 d after operation.
Slices were incubated for various times in medium
containing [14Clglucosamine. At the end of incubation
the explants were washed free of extracellular [14C]glu-
cosamine, homogenized, and the radioactivity in the
trichloroacetic acid-soluble material was assayed. The
mean values ± S.D. of 8 determinations for each time
point are listed.
Time of
incubation
0.5 h
1 h
2 h
4 h
6 h
Intracellular [14CJhexosamine
Bq/mg protein
Regenerating
liver
25 ± 8
105 ± 20
605 ± 106
665 ± 86
672 ± 128
Sham-operated
liver
30 ± 8
83 ± 22
635 ± 163
688 ± 106
706 ±183
Tab. 4. The size of the precursor (UDP-N-acetylhexosamine)
pool of glycosairimoglycan synthesis in regenerating and
sham-operated rat liver 1 d after operation.
UDP^N-acetylhexosamine was isolated from the livers by
a combination of ion-exchange and paper chromatogra·*
phic procedures. Its absorbancy at 260 nm was measured
and used for quantitation by means of ä standard curve
containing known amounts of UDP-N^acetylglucosamine.
The values are the mean ± S.D. The number of rats
studied is given in parenthesis.
Treatment of rats ÜDP-N-acetylhexosamine
in liver
(nmol/mg protein)
Partial hepatectomy (10)
Sham-operation (12)
31 ±3
27 ±4 P = 0.016
glucosamine by regenerating liver slices as the cause of
its diminished incorporation into glycosaminoglycans.
The concentration of UDP-N-acetylhexosamine, the
immediate precursor of giycosaminoglycan chain syn-
thesis, showed a slight, but statistically significant differ-
ence in sham-operated and regenerating liver 1 d after
operation (tab. 4). The latter contained about 15% more
ubP-N-acetylhexosamine than the former. If the rate of
incorporation 1 day after partial hepatectomy is corrected
for the different precursor pool sizes the synthesis of
hepatic glycosaminoglycans in regenerating liver tissue
remains significantly reduced (p = 0.030) in comparison
with sham-operated livers (tab. 1).
Discussion
The experiments described here demonstrate, a signi-
ficant depression of the incorporation of labeled glucos-
amine into glycosaminoglycans of regenerating liver
tissue in vitro. Cellular uptake of the amino sugar did
not differ in the two types of slices, the pool size of
UDP-N-acetylhexosamine was only slightly larger in
regenerating than in sham-operated liver tissue and
the incorporation of [l4C]glucosamine into UDP-N-
acetylhexosamine determined under quite similar ex-
perimental conditions was reported not to be decreased
(in fact increased) 6 to 48 h after partial hepatectomy
(27). The data therefore most likely reflect diminished
synthesis of hepatic glycosaminoglycans, defined as the
transfer of N-acetylhexosamine from UDP-N-acetyl-
J. Clin. Chem. Cun. Biochem. / VoL 19,1981 / No. 7
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hexosamine into the polysaccharide chain of glycos-
aminoglycans. Our finding of lowered glycosamino-
glycan synthesis in regenerating liver is in accordance
with a similar decrease in glycoprotein synthesis in the
early stages after partial hepatectomy (27, 28), but
contrary results have also been reported (29). It is
remarkable that the proportion of the synthesis of
heparan sulfate and chondroitin sulfate did not change
in the regenerating tissue; this indicates similar, as yet
only partly understood regulatroy mechanism for both
types of glycosaminoglycans. Among other factors
(30) the increase in the concentration of cyclic AMP
in regenerating liver tissue (31,32) might control gly-
cosaminoglycan production, since the cyclic nucleo-
tide reduces the synthesis of both heparan sulfate and
chondroitin sulfate to nearly the same extent in liver
slices (33). The increase in glycosaminoglycan produc-
tion in regenerating tissue in comparison with sham-
operated liver 6 h after operation could be a conse-
quence of the significant decrease in intracellular cyclic
AMP concentration observed in the very early phase
after partial hepatectomy (31, 32), which in turn may
be caused by release of insulin in the first few minutes
after operation (34). In addition, prostaglandins and
thromboxane might exert some, as yet not investigated
effects on the synthesis of proteoglycans in regenerating
liver (22, 35).
Our results show that liver cell regeneration by itself
does not produce an increase in glycosaminoglycan
synthesis and, hence, cannot be responsible for the
enhanced production of proteoglycans observed in
acutely and chronically damaged liver tissue (15-18).
Thus proteoglycan synthesis behaves differently from the
biosynthetic pathway of collagens. The synthesis of the
latter matrix molecules is stimulated in proliferating
liver as indicated by the higher activity of collagen-
prolylhydroxyläse in regenerating liver (36, 37) and
in the parenchymal cells isolated from regenerating
tissue (38). In addition, the typical occurrence of a
trimer of type I collagen ([al(I)]a) in cirrhotic livers
(39) was proposed to be a biosynthetic product of the
replicating hepatocytes (40).
Obviously glycosaminoglycan synthesis and content in
liver is inversely related to the proliferate tendency
of the cells. In mitosis-induced liver the nuclear content
of glycosaminoglycans is reduced significantly (41),
the cell coat glycosaminoglycans disappear temporarily
(42—44) and the mucopolysaccharides surrounding hepa-
toma cells differ markedly from those attached to normal
liver cells (45, 46). Furthermore, liver tumor cells (Novi-
koff hepatoma) synthesize less heparan sulfate than the
normal counterpart (47) and density-dependent inhibi-
tion of hepatoma cell growth in culture is restored by
addition of cell coat acid mucopolysaccharides (48). The
predominant role in this process is played by cell surface
heparan sulfate (45, 49). As reported very recently (50)
the concentration of heparan sulfate does not change
significantly in regenerating liver tissue, whereas that of
chondroitin sulfate and, less marked, that of dermatan
sulfate show biphasic temporal changes in the regener-
ating liver. From our results it appears that the time-
dependent changes in the concentration of glycos-
aminoglycans (in particular of the ratio chondroitin
sulfate to dermatan sulfate) in the regenerating liver
tissue cannot be explained solely on the basis of their
biosynthetic rates in vitro. But it should be emphasized
that hepatic glycosaminoglycan synthesis in vivo is
exposed to several additional, mainly humoral factors
which can affect the profile of glycosaminoglycan
production and, thus, are responsible for some differ-
ences between glycosaminoglycan synthesis ex vivo
(liver explants) and in vivo (liver in situ) (51).
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